nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An issue of trust—vaccinating Black patients against COVID-19
|
Okorodudu, Dale O |
|
|
9 |
3 |
p. 228-229 |
artikel |
2 |
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|
Zhou, Caicun |
|
|
9 |
3 |
p. 305-314 |
artikel |
3 |
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
|
Piroth, Lionel |
|
|
9 |
3 |
p. 251-259 |
artikel |
4 |
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
|
Cohen, Jordana B |
|
|
9 |
3 |
p. 275-284 |
artikel |
5 |
Correction to Lancet Respir Med 2020; 8: 873–84
|
|
|
|
9 |
3 |
p. e29 |
artikel |
6 |
Correction to Lancet Respir Med 2020; 8: 963–74
|
|
|
|
9 |
3 |
p. e29 |
artikel |
7 |
Correction to Lancet Respir Med 2020; published online Dec 22. https://doi.org/10.1016/S2213-2600(20)30414-8
|
|
|
|
9 |
3 |
p. e29 |
artikel |
8 |
Correction to Lancet Respir Med 2021; published online Jan 8. https://doi.org/10.1016/S2213-2600(20)30552-X
|
|
|
|
9 |
3 |
p. e29 |
artikel |
9 |
Correction to Lancet Respir Med 2020; published online October 20. https://doi.org/10.1016/S2213-2600(20)30391-X
|
|
|
|
9 |
3 |
p. e29 |
artikel |
10 |
COVID-19: a heavy toll on health-care workers
|
Mehta, Sangeeta |
|
|
9 |
3 |
p. 226-228 |
artikel |
11 |
COVID-19 is not influenza
|
Petersen, Eskild |
|
|
9 |
3 |
p. 219-220 |
artikel |
12 |
Each person is a world in COVID-19
|
Ely, E Wesley |
|
|
9 |
3 |
p. 236-237 |
artikel |
13 |
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
|
|
|
|
9 |
3 |
p. 295-304 |
artikel |
14 |
How IPF has changed our lives
|
Maxine, |
|
|
9 |
3 |
p. 232-233 |
artikel |
15 |
Implications of COVID-19 sequelae for health-care personnel
|
Praschan, Nathan |
|
|
9 |
3 |
p. 230-231 |
artikel |
16 |
Instrumental dead space in ventilator management
|
Lellouche, François |
|
|
9 |
3 |
p. e22 |
artikel |
17 |
Instrumental dead space in ventilator management – Authors' reply
|
Schultz, Marcus J |
|
|
9 |
3 |
p. e23 |
artikel |
18 |
My COVID-19 dream: training enough health workers
|
Tulenko, Kate |
|
|
9 |
3 |
p. e26 |
artikel |
19 |
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
|
Harrison, Tim W |
|
|
9 |
3 |
p. 260-274 |
artikel |
20 |
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study
|
Pun, Brenda T |
|
|
9 |
3 |
p. 239-250 |
artikel |
21 |
Provision of holistic care after severe COVID-19 pneumonia
|
McPeake, Joanne |
|
|
9 |
3 |
p. e24 |
artikel |
22 |
Provision of holistic care after severe COVID-19 pneumonia – Authors' reply
|
D'Cruz, Rebecca F |
|
|
9 |
3 |
p. e25 |
artikel |
23 |
Racial microaggressions within respiratory and critical care medicine
|
Babla, Kunal |
|
|
9 |
3 |
p. e27-e28 |
artikel |
24 |
Renin-angiotensin system inhibitors in hospitalised patients with COVID-19
|
Williams, Bryan |
|
|
9 |
3 |
p. 221-222 |
artikel |
25 |
Risks of lung transplantation in the SARS-CoV-2 era
|
Meyer, Keith C |
|
|
9 |
3 |
p. 224-226 |
artikel |
26 |
Sedation in mechanically ventilated patients with COVID-19
|
Page, Valerie |
|
|
9 |
3 |
p. 218-219 |
artikel |
27 |
Successful double-lung transplantation from a donor previously infected with SARS-CoV-2
|
Ceulemans, Laurens J |
|
|
9 |
3 |
p. 315-318 |
artikel |
28 |
Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation study
|
Duckworth, Anna |
|
|
9 |
3 |
p. 285-294 |
artikel |
29 |
The Biden administration: changing the tide for health?
|
The Lancet Respiratory Medicine, |
|
|
9 |
3 |
p. 217 |
artikel |
30 |
The right place for IL-1 inhibition in COVID-19
|
Cavalli, Giulio |
|
|
9 |
3 |
p. 223-224 |
artikel |
31 |
Touch, and the absence of it
|
Heidari, Shireen N |
|
|
9 |
3 |
p. 233-234 |
artikel |
32 |
Untouched
|
Ray, Animesh |
|
|
9 |
3 |
p. 234-235 |
artikel |
33 |
Visionary insight
|
Quadri, Nasreen |
|
|
9 |
3 |
p. 237-238 |
artikel |